Skip to navigation Skip to main content

CME/CE

CME/CE Courses


Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.


Featured Courses

BRAINWeekEnd: A 3-Part Review Addressing Management and Treatment Options for Relapsing Remitting MS, Schizophrenia, and Parkinson’s Disease

BRAINWeekEnd: A 3-Part Review Addressing Management and Treatment Options for Relapsing Remitting MS, Schizophrenia, and Parkinson’s Disease | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), AANP Contact Hour(s), CE for Pharmacists
A rising geriatric population, increased life expectancy, and the anticipated launch of novel molecules are driving the need for continuing medical education for clinicians treating neurological disorders. This BRAINWeek Highlights activity presents three timely and relevant presentations focused on the most commonly diagnosed CNS conditions.
Connecting Care: Expert Answers About COVID-19 Treatment With Neutralizing Monoclonal Antibodies

COVID Treatment With Monoclonal Antibodies | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), AANP Contact Hour(s), CE for Pharmacists
.75 CME CE. Addresses clinician questions about the science and practical issues of using monoclonal antibodies to treat patients with COVID-19. Exp 2/27/22
Racial and Genetic Implications for MS Treatment Selection

Racial and Genetic Implications for MS Treatment Selection

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
This online session will explore differences in the prevalence and incidence of Multiple Sclerosis based on gender and race, as well as the implications for treatment selection and management of side effects.
Immune Pathways in Systemic Lupus Erythematosus (SLE)

Immune Pathways in Systemic Lupus Erythematosus (SLE) | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
The first episode of this CMEOCast podcast series on systemic lupus erythematosus (SLE) focuses on the heterogeneity of lupus, including the multiple immune pathways that are active in it and how knowledge of immunopathogenesis has informed drug development.
Safety and Efficacy of Emerging Treatments in the Management of Systemic Lupus Erythematosus (SLE)

Safety and Efficacy of Emerging Treatments for SLE | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
The future is bright for patients with lupus, as drug development activities are currently unprecedented. In this CMEOCast podcast episode, expert faculty evaluate the safety and efficacy of emerging therapies.
Improving the Application of Shared Decision-Making in the Selection of SLE Treatments

Shared Decision-Making in the Selection of SLE Treatments | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
The final episode in this CMEOCast podcast series on SLE addresses the impact and burden of SLE on quality of life, the integration of PROs when caring for patients with SLE, and the implementation of best practices for SDM in order to engage patients as partners in their care.
Finding Function: A Holistic Approach to Managing Osteoarthritis

Finding Function: A Holistic Approach to Managing Osteoarthritis | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
In this installment of the CME Outfitters Snack series on managing osteoarthritis, expert faculty discuss the use of patient-reported outcomes, patient education, biopsychosocial approaches that integrate non-pharmacological interventions for OA, and strategies for engaging patients in their treatment decisions, in order to facilitate proper management of OA.
Implementing a Multidisciplinary Approach to Prevention and Diagnosis of CDI

Implementing a Multidisciplinary Approach to Prevention and Diagnosis of CDI | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
Accurate diagnosis of Clostridioides difficile infection (CDI) remains an important clinical challenge. In this educational activity, 2 experts provide a comprehensive review of all validated tools and measures for making a definitive diagnosis of CDI, as well as various strategies for preventing the transmission of C difficile.
A Personalized Approach to Optimizing Immunoglobulin Therapy in Patients with Primary Immunodeficiency

Immunoglobulin Therapy in Patients with PID | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
.5 CME CE Provides important insights into selecting the correct therapies and dosing, managing adverse effects to optimize patient outcomes. Exp 10/29/22
Adopting a Tailored Approach to Managing Unmet Needs in Osteoarthritis

Adopting a Tailored Approach to Managing Unmet Needs in Osteoarthritis | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
This CME Outfitters Snack focuses on recognizing the complex pathogenesis of OA, applying The Osteoarthritis Research Society International (OARSI) guidelines to non-surgical management, and evaluating emerging data in order to set realistic goals with patients and meet unmet needs in the management of OA.

More

Comprehensive Review of Urology | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
Optimize patient outcomes with this expertly informed CME program detailing the latest advancements and emerging issues in the field of urology. Learn more.

IBD: Best Practices in Transitional Care | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
0.75 CME CE Features expert faculty discussing recommended immunizations and preventive screenings for patients with IBD. Exp 1/12/23

Strategies for Severe Vernal Keratoconjunctivitis

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), COPE CE Credit(s)
1 CME CE Podcast discusses properly diagnosing and treating VKC according to disease severity, and differentiating it from other ocular allergies. Exp 11/22